Gene Therapy & Gene Editing
Part of Healthcare - Genomics & Precision Medicine
| Ticker | Company | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|
 VRTX | Vertex Pharmaceuticals Inc | $113.6b | $446.93 | +1.2% | 1.5M |
 REGN | Regeneron Pharmaceuticals Inc | $64.5b | $635.40 | +1.1% | 975.8K |
 INSM | Insmed, Inc. | $23.2b | $94.15 | -10.3% | 8.0M |
 BMRN | BioMarin Pharmaceuticals Inc | $11.1b | $56.76 | +0.5% | 2.2M |
 KRYS | Krystal Biotech, Inc. Common Stock | $9.1b | $300.46 | -2.4% | 264.5K |
 CRSP | CRISPR Therapeutics AG | $5.4b | $51.86 | -8.9% | 2.3M |
 FOLD | Amicus Therapeutics, Inc | $4.5b | $14.49 | +0.0% | 3.5M |
 BEAM | Beam Therapeutics Inc. Common Stock | $3.4b | $29.34 | -10.7% | 2.4M |
 NTLA | Intellia Therapeutics, Inc | $2.0b | $13.30 | -9.8% | 7.5M |
 SRPT | Sarepta Therapeutics,, Inc. Common Stock | $1.9b | $15.75 | -5.5% | 2.7M |
 QURE | uniQure N.V. | $1.8b | $26.54 | -5.2% | 1.5M |
 VCEL | Vericel Corporation | $1.7b | $36.30 | +1.7% | 558.3K |
 TSHA | Taysha Gene Therapies, Inc. Common Stock | $1.7b | $5.50 | -6.6% | 1.4M |
 PGEN | Precigen, Inc. Common Stock | $1.5b | $3.56 | -7.8% | 5.3M |
 BLFS | BioLife Solutions Inc. | $1.2b | $26.65 | -1.6% | 701.9K |
 MGTX | MeiraGTx Holdings plc Ordinary Shares | $1.0b | $9.00 | -6.0% | 693.7K |
 SANA | Sana Biotechnology, Inc. Common Stock | $0.9b | $2.68 | -9.5% | 4.7M |
 PCRX | Pacira BioSciences, Inc. Common Stock | $0.9b | $22.73 | +0.3% | 402.7K |
 CYRX | CryoPort, Inc. Common Stock | $0.8b | $15.70 | -2.9% | 710.8K |
 ALLO | Allogene Therapeutics, Inc. Common Stock | $0.7b | $1.88 | -8.1% | 8.0M |
 SLDB | Solid Biosciences Inc. Common Stock | $0.7b | $6.71 | -7.4% | 701.7K |
 DSGN | Design Therapeutics, Inc. Common Stock | $0.7b | $10.64 | -1.1% | 791.3K |
 PRME | Prime Medicine, Inc. Common Stock | $0.6b | $3.06 | -11.8% | 4.5M |
 CABA | Cabaletta Bio, Inc. Common Stock | $0.6b | $3.23 | -7.8% | 4.3M |
 EDIT | Editas Medicine, Inc. Common Stock | $0.5b | $2.70 | -9.7% | 2.4M |
 FDMT | 4D Molecular Therapeutics, Inc. Common Stock | $0.5b | $8.64 | -13.7% | 644.7K |
 KYTX | Kyverna Therapeutics, Inc. Common Stock | $0.5b | $7.45 | -6.3% | 617.4K |
 OCGN | Ocugen, Inc. Common Stock | $467.2m | $1.29 | -5.8% | 5.3M |
 NGNE | Neurogene, Inc. Common Stock | $447.8m | $26.18 | -4.7% | 67.4K |
 LXEO | Lexeo Therapeutics, Inc. Common Stock | $403.6m | $4.35 | -9.0% | 465.6K |
 BNTC | Benitec Biopharma Inc. Common Stock | $397.1m | $10.56 | -4.4% | 42.2K |
 RGNX | REGENXBIO Inc. | $362.4m | $6.07 | -11.8% | 1.7M |
 IRD | Opus Genetics, Inc. Common Stock | $354.9m | $4.05 | -12.7% | 1.0M |
 RCKT | Rocket Pharmaceuticals, Inc. Common Stock | $335.2m | $2.74 | -6.2% | 2.6M |
 ABEO | Abeona Therapeutics Inc. Common Stock | $329.4m | $5.47 | -6.0% | 881.9K |
 TRDA | Entrada Therapeutics, Inc. Common Stock | $274.5m | $6.38 | -8.9% | 195.0K |
 CRBU | Caribou Biosciences, Inc. Common Stock | $234.1m | $1.93 | -6.8% | 1.7M |
 VYGR | Voyager Therapeutics, Inc. Common Stock | $233.8m | $3.33 | -8.2% | 650.9K |
 KRRO | Korro Bio, Inc. Common Stock | $193.4m | $10.61 | -5.1% | 187.7K |
 TNYA | Tenaya Therapeutics, Inc. Common Stock | $188.6m | $0.73 | -5.7% | 4.5M |
 DTIL | Precision BioSciences, Inc. Common Stock | $179.8m | $6.50 | +1.4% | 253.3K |
 GNLX | Genelux Corporation Common Stock | $136.8m | $2.92 | -5.2% | 166.2K |
 MXCT | MaxCyte, Inc. Common Stock | $129.6m | $1.15 | -6.9% | 900.8K |
 ENGN | enGene Therapeutics Inc. Common Stock | $123.9m | $1.65 | -4.1% | 954.4K |
 CBUS | Cibus, Inc. Class A Common Stock | $109.9m | $1.29 | -7.9% | 449.0K |
 INO | Inovio Pharmaceuticals, Inc. | $107.8m | $1.06 | -8.2% | 3.3M |
 SGMO | Sangamo Therapeutics, Inc. Common Stock | $83.3m | $0.18 | -15.8% | 2.0M |
 TCRX | TScan Therapeutics, Inc. Common Stock | $70.6m | $0.98 | -4.0% | 313.2K |
 TIL | Instil Bio, Inc. Common Stock | $54.7m | $8.07 | -0.9% | 6.3K |
 MGX | Metagenomi Therapeutics, Inc. Common Stock | $51.2m | $1.28 | -3.4% | 274.6K |